Reducing smoking by half in COPD patients: Does it reduce FEV1 decline?

被引：4
|
作者：
Peiffer, G. [1 ]
Perriot, J. [2 ,3 ]
Underner, M. [4 ,5 ]
机构：
[1] Hop Metz, CHR Metz Thionville, Serv Pneumol, Ctr Tabacol, F-57038 Metz 3, France
[2] Ctr Tabacol, Dispensaire Emile Roux, F-63100 Clermont Ferrand, France
[3] Ctr Lutte AntiTB CLAT 63, F-63100 Clermont Ferrand, France
[4] CHU Poitiers, Serv Pneumol, Unite Tabacol, F-86000 Poitiers, France
[5] CHU Poitiers, Ctr Lutte AntiTB CLAT 63, F-86000 Poitiers, France
来源：
REVUE DES MALADIES RESPIRATOIRES | 2017年 / 34卷 / 03期
关键词：
NICOTINE REPLACEMENT THERAPY; LUNG HEALTH; CESSATION; DISEASE; SMOKERS; SAFETY; RISK;
D O I：
10.1016/j.rmr.2016.10.872
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：177 / 179
页数：3
相关论文
共 50 条
  • [41] Biomarkers to predict FEV1 decline in smokers and early-onset COPD
    Gotera, Carolina
    Pereira Vega, Antonio
    Garcia Barrera, Tamara
    Marin Trigo, Jose Maria
    Casanova Macario, Ciro
    Garcia-Cosio Piqueras, Borja
    Mir Viladrich, Isabel
    Solanes Garcia, Ingrid
    Gomez Ariza, Jose Luis
    Lopez Campos, Jose Luis
    Seijo Maceiras, Luis
    Feu Collado, Nuria
    Cabrera Lopez, Carlos
    Amado Diago, Carlos
    Romero Plaza, Amparo
    De Torres Tajes, Juan Pablo
    Padron Fraysse, Luis Alejandero
    Marquez Martin, Eduardo
    Marin Royo, Margarita
    Balcells Vilarnau, Eva
    Llunell Casanovas, Antonia
    Martinez Gonzalez, Cristina
    Galdiz Iturri, Juan Bautista
    Lacarcel Bautista, Celia
    Garcia Garrido, Sandra
    Peces-Barba, German
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [42] Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial
    Steven Kesten
    Bartolome Celli
    Marc Decramer
    Dacheng Liu
    Donald Tashkin
    Respiratory Research, 12
  • [43] Contributions of Emphysema and Small Airway Diseases Assessed by CT to Predict FEV1 Decline in Patients with COPD
    Oguma, A.
    Shimizu, K.
    Suzuki, M.
    Makita, H.
    Konno, S.
    Nishimura, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] Smoking cessation -: but not smoking reduction -: improves the annual decline in FEV1 in occupationally exposed workers
    Bohadana, Abraham B.
    Nilsson, Fredrik
    Westin, Ake
    Martinet, Nadine
    Martinet, Yves
    RESPIRATORY MEDICINE, 2006, 100 (08) : 1423 - 1430
  • [45] Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications
    Tashkin, D. P.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (02)
  • [46] VALIDITY OF FEV6, FEV1/FEV6 RATIO OVER FEV1% IN THE DIAGNOSIS OF COPD
    Kuruvila, Neenu
    Shenoy, Saritha J.
    Venugopal, Kummannoor Parameshwaran
    Madhavikutty, Geethadevi
    Sameena, B.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (25): : 1988 - 1992
  • [47] Decline of FEV1 by age and smoking status: facts, figures, and fallacies - Commentary
    Moxham, J
    THORAX, 1997, 52 (09) : 828 - 829
  • [48] Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial
    Kesten, Steven
    Celli, Bartolome
    Decramer, Marc
    Liu, Dacheng
    Tashkin, Donald
    RESPIRATORY RESEARCH, 2011, 12
  • [49] Systematic review of the evidence relating FEV1 decline to giving up smoking
    Lee, Peter N.
    Fry, John S.
    BMC MEDICINE, 2010, 8
  • [50] Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
    Whittaker, Hannah R.
    Bloom, Chloe
    Morgan, Ann
    Jarvis, Deborah
    Kiddle, Steven J.
    Quint, Jennifer K.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (03)
12345